FLT3 and acute myeloid leukemia: NOX4 has been shown to be a STAT5 target gene, and its upregulation in FLT3/ITD+ AML mediates leukemic transformation through inactivation of protein tyrosine phosphatases (PTPs) such as DEP-1 by causing reversible cysteine oxidation at their catalytic site.